Current Ratio of Nurix Therapeutics, Inc. from 31 May 2021 to 31 Aug 2025

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Nurix Therapeutics, Inc. quarterly Current Ratio in % history and change rate from 31 May 2021 to 31 Aug 2025.
  • Nurix Therapeutics, Inc. Current Ratio for the quarter ending 31 Aug 2025 was 622%, a 46% increase year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Change (%)

Nurix Therapeutics, Inc. Quarterly Current Ratio (%)

Period Value YoY Chg Change % Date
Q3 2025 622% +197% +46% 31 Aug 2025
Q2 2025 620% +220% +55% 31 May 2025
Q1 2025 592% +234% +65% 28 Feb 2025
Q4 2024 507% +107% +27% 30 Nov 2024
Q3 2024 425% -7.3% -1.7% 31 Aug 2024
Q2 2024 399% -56% -12% 31 May 2024
Q1 2024 358% -102% -22% 29 Feb 2024
Q4 2023 400% -56% -12% 30 Nov 2023
Q3 2023 433% -27% -6% 31 Aug 2023
Q2 2023 455% -37% -7.5% 31 May 2023
Q1 2023 460% -126% -21% 28 Feb 2023
Q4 2022 455% -195% -30% 30 Nov 2022
Q3 2022 460% -258% -36% 31 Aug 2022
Q2 2022 492% -268% -35% 31 May 2022
Q1 2022 586% 28 Feb 2022
Q4 2021 650% 30 Nov 2021
Q3 2021 718% 31 Aug 2021
Q2 2021 759% 31 May 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.